Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Maintains Outperform on Compugen, Lowers Price Target to $14

Oppenheimer analyst Mark Breidenbach maintains Compugen (NASDAQ:CGEN) with a Outperform and lowers the price target from $17 to $14.
byBenzinga Newsdesk
February 25, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oppenheimer analyst Mark Breidenbach maintains Compugen (NASDAQ:CGEN) with a Outperform and lowers the price target from $17 to $14.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0